Bioelectronics Corp (BIEL)

[514]

''Several people have mentioned on the yahoo boards that with some companies FDA approval led to a decline in the stock PPS, because FDA approval doesn’t mean anything if you don’t have the muscle or means to market your product in the end. ”

That is exactly what happened with Nuvo Research ( NRI.TO )

Knowing that biel has already a plan to market as soon they recieve FDA OTC cleareance is very positive.

( i'm starting to doubt , not b/c of the product , i just don't like the waiting game )